Form 4: Aveanna Healthcare Holdings Director Sells Shares Under 10b5-1 Plan
SEC Form 4 Filing
Paul R. Vigano, a director of Aveanna Healthcare Holdings, reported the sale of common stock through entities associated with J.H. Whitney Capital Partners, LLC, under a pre-arranged 10b5-1 trading plan.
Summary
- Paul R. Vigano, a director of Aveanna Healthcare Holdings, Inc., reported the sale of common stock on May 8 and May 9, 2025.
- The sales were executed under a Rule 10b5-1 trading plan adopted on December 13, 2024, by J.H. Whitney VII, L.P. and affiliated entities.
- On May 8, 2025, 52,656 shares were sold at a weighted average price of $5.84, with prices ranging from $5.62 to $6.10.
- On May 9, 2025, 4,034 shares were sold at a weighted average price of $5.65, with prices ranging from $5.62 to $5.71.
- The sales were conducted through various entities including J.H. Whitney VII, L.P., PSA Healthcare Investment Holding LLC, JHW Iliad Holdings LLC, PSA Iliad Holdings LLC, and JHW Iliad Holdings II LLC.
- Vigano disclaims beneficial ownership of the securities except to the extent of his pecuniary interest therein.
- Following the reported transactions, the entities associated with J.H. Whitney VII, L.P. indirectly hold 31,319,404 shares of Aveanna Healthcare Holdings, Inc.
Sentiment
Score: 5
Explanation: The document is a standard SEC filing reporting stock sales by a director under a pre-arranged trading plan. It doesn't inherently convey positive or negative sentiment, but the market's reaction to insider sales can vary.
Positives
- The sales were conducted under a pre-arranged 10b5-1 trading plan, indicating they were planned in advance and not based on immediate market conditions.
Risks
- The sale of shares by a director, even under a pre-arranged plan, could be perceived negatively by investors.
Industry Context
Sales by insiders are a common occurrence, and the use of 10b5-1 plans is a standard practice to avoid accusations of trading on inside information. The impact on the stock price depends on the size of the sale relative to the overall trading volume and investor sentiment.
Stakeholder Impact
- The stock sale could potentially impact shareholder sentiment, depending on how the market interprets the transaction.
Key Dates
| Date | Description |
|---|---|
| 2024-12-13 | Date of adoption of Rule 10b5-1 trading plan |
| 2025-05-08 | Date of first reported transaction |
| 2025-05-09 | Date of second reported transaction |
| 2025-05-12 | Date of signature on the Form 4 |
Keywords
Form 4, Aveanna Healthcare Holdings, AVAH, Paul R. Vigano, J.H. Whitney Capital Partners, Stock Sale, 10b5-1 Trading Plan, Director
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.